{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:50:52Z","timestamp":1790279452313,"version":"4.1.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi220927-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>\n                      Obtaining follow-up blood cultures (FUBCs) in patients with\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      bloodstream infection (BSI) is standard practice, although its utility in patients with gram-negative bacterial BSI (GN-BSI) is unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi220927-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine whether obtaining FUBCs is associated with decreased mortality (key question [KQ] 1) and whether positive vs negative FUBCs are associated with increased mortality (KQ2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi220927-6\">\n                    <jats:title>Data Sources<\/jats:title>\n                    <jats:p>MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Web of Science, and gray literature were searched from inception to March 11, 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi220927-7\">\n                    <jats:title>Study Selection<\/jats:title>\n                    <jats:p>Two investigators used predefined eligibility criteria to independently screen titles, abstracts, and relevant full texts. Randomized clinical trials or observational studies that matched or statistically adjusted for differences in, at minimum, level of acute illness between patients in the intervention (eg, FUBCs obtained) and control (eg, FUBCs not obtained) groups were included in primary analyses. Articles published in languages other than English were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi220927-8\">\n                    <jats:title>Data Extraction and Synthesis<\/jats:title>\n                    <jats:p>Data abstraction and quality assessments were performed by one investigator and verified by a second investigator. Risk of bias was assessed with the Newcastle-Ottawa Scale. Effect sizes were pooled using random-effects models. The study followed the Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guideline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi220927-9\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Mortality before hospital discharge or up to 30 days from the index blood culture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi220927-10\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 3495 studies, 15 were included (all nonrandomized). In the 5 studies (n\u2009=\u20094378 patients) that met criteria for the KQ1 primary analysis, obtaining FUBCs was associated with decreased mortality (hazard ratio, 0.56; 95% CI, 0.45-0.71). For KQ2, 2 studies met criteria for the primary analysis (ie, matched or statistically adjusted for differences in patients with positive vs negative FUBCs), so an exploratory meta-analysis of all 9 studies that investigated KQ2 (n\u2009=\u20093243 patients) was performed. Positive FUBCs were associated with increased mortality relative to negative blood cultures (odds ratio, 2.27; 95% CI, 1.54-3.34). Limitations of the literature included a lack of randomized studies and few patient subgroup analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi220927-11\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this systematic review and meta-analysis, obtaining FUBCs in patients with GN-BSI was associated with decreased mortality. The benefit of FUBCs may stem from identification of patients with positive FUBCs, which was a poor prognostic marker.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.32576","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T12:24:49Z","timestamp":1663849489000},"page":"e2232576","source":"Crossref","is-referenced-by-count":34,"title":["Association of Follow-up Blood Cultures With Mortality in Patients With Gram-Negative Bloodstream Infections"],"prefix":"10.1001","volume":"5","author":[{"given":"Joshua T.","family":"Thaden","sequence":"first","affiliation":[{"name":"Duke University Division of Infectious Diseases, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cantrell","sequence":"additional","affiliation":[{"name":"Duke University Medical Center Library & Archives, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dagher","sequence":"additional","affiliation":[{"name":"Duke University Division of Infectious Diseases, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhong","family":"Tao","sequence":"additional","affiliation":[{"name":"Duke University Division of Infectious Diseases, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Ruffin","sequence":"additional","affiliation":[{"name":"Duke University Division of Infectious Diseases, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey A.","family":"Maskarinec","sequence":"additional","affiliation":[{"name":"Duke University Division of Infectious Diseases, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Goins","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Duke University Division of Nephrology, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Parsons","sequence":"additional","affiliation":[{"name":"Duke University Division of Infectious Diseases, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Eichenberger","sequence":"additional","affiliation":[{"name":"Duke University Division of Infectious Diseases, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Vance G.","family":"Fowler","sequence":"additional","affiliation":[{"name":"Duke University Division of Infectious Diseases, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"issue":"4","key":"zoi220927r1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.02429-21","article-title":"Prevalence and mortality associated with bloodstream organisms: a population-wide retrospective cohort study.","volume":"60","author":"Verway","year":"2022","journal-title":"J Clin Microbiol"},{"issue":"6","key":"zoi220927r2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/1469-0691.12195","article-title":"Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe.","volume":"19","author":"Goto","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"zoi220927r3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study.","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"zoi220927r4","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2014.9743","article-title":"Clinical management of Staphylococcus aureus bacteremia: a review.","volume":"312","author":"Holland","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"zoi220927r5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cmi.2020.01.025","article-title":"Positive follow-up blood cultures identify high mortality risk among patients with gram-negative bacteraemia.","volume":"26","author":"Maskarinec","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"zoi220927r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2021.115444","article-title":"Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia.","volume":"101","author":"Clemmons","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"zoi220927r7","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cmi.2020.01.023","article-title":"Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study.","volume":"26","author":"Giannella","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"zoi220927r8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12879-016-1622-z","article-title":"Sending repeat cultures: is there a role in the management of bacteremic episodes? (SCRIBE study).","volume":"16","author":"Wiggers","year":"2016","journal-title":"BMC Infect Dis"},{"key":"zoi220927r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100811","article-title":"Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection.","volume":"34","author":"Amipara","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"1","key":"zoi220927r10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1186\/s12879-020-05395-8","article-title":"Predictive scoring models for persistent gram-negative bacteremia that reduce the need for follow-up blood cultures: a retrospective observational cohort study.","volume":"20","author":"Jung","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"5","key":"zoi220927r11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s10096-020-04141-x","article-title":"Follow-up blood cultures in E. coli and Klebsiella spp. bacteremia-opportunities for diagnostic and antimicrobial stewardship.","volume":"40","author":"Chan","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"zoi220927r12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS: Peer Review of Electronic Search Strategies\u20142015 Guideline Statement.","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"zoi220927r14","doi-asserted-by":"publisher","first-page":"746","DOI":"10.12788\/jhm.2900","article-title":"The changing landscape of uncomplicated gram-negative bacteremia: a narrative review to guide inpatient management.","volume":"15","author":"Chan","year":"2020","journal-title":"J Hosp Med"},{"issue":"4","key":"zoi220927r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106320","article-title":"Quality of care indicators in the Management of Bloodstream Infections Caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda.","volume":"57","author":"Giannella","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"zoi220927r16","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/cid\/ciaa039","article-title":"Does this patient need blood cultures? a scoping review of indications for blood cultures in adult nonneutropenic inpatients.","volume":"71","author":"Fabre","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"12","key":"zoi220927r17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/antibiotics9120895","article-title":"Are follow-up blood cultures useful in the antimicrobial management of gram negative bacteremia? a reappraisal of their role based on current knowledge.","volume":"9","author":"Cogliati Dezza","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"zoi220927r18","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy087","article-title":"Top questions in uncomplicated, non-staphylococcus aureus Bacteremia.","volume":"5","author":"Sutton","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"zoi220927r21","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2021.184","article-title":"Follow-up blood cultures in Pseudomonas aeruginosa bacteremia: a potential target for diagnostic stewardship.","volume":"1","author":"Green","year":"2021","journal-title":"Antimicrob Stewardship Healthcare Epidemiol"},{"key":"zoi220927r22","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.1093\/ofid\/ofab466.381","article-title":"Follow-up blood cultures for gram-negative bacilli bacteremia were associated with prolonged length of hospital stay and duration of antibiotic treatment: a propensity score\u2013matched cohort study.","volume":"8","author":"Mitaka","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"zoi220927r23","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/(ISSN)1097-0258","article-title":"On tests of the overall treatment effect in meta-analysis with normally distributed responses.","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat Med"},{"issue":"24","key":"zoi220927r24","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1002\/(ISSN)1097-0258","article-title":"A refined method for the meta-analysis of controlled clinical trials with binary outcome.","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat Med"},{"issue":"7109","key":"zoi220927r25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"11","key":"zoi220927r26","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jclinepi.2014.11.023","article-title":"Grading the strength of a body of evidence when assessing health care interventions: an EPC update.","volume":"68","author":"Berkman","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"zoi220927r27","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1093\/ofid\/ofab466.291","article-title":"Follow-up blood cultures (FUBC) in the management of gram-negative bacilli (GNB) bloodstream infections (BSIs): frequently obtained and rarely helpful.","volume":"8","author":"Robinson","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"zoi220927r28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.23736\/S0375-9393.20.14040-9","article-title":"Follow-up blood cultures in gram-negative bacilli bacteremia: are they needed for critically ill patients?","volume":"86","author":"Spaziante","year":"2020","journal-title":"Minerva Anestesiol"},{"issue":"4","key":"zoi220927r29","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa110","article-title":"Risk factors for positive follow-up blood cultures in gram-negative bacilli bacteremia: implications for selecting who needs follow-up blood cultures.","volume":"7","author":"Mitaka","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"zoi220927r30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s15010-021-01742-2","article-title":"Bedside risk prediction for positive follow-up blood culture in gram-negative bacilli bacteremia: for whom is follow-up blood culture useful?","volume":"50","author":"Kim","year":"2022","journal-title":"Infection"},{"key":"zoi220927r31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/1471-2334-13-365","article-title":"Can a routine follow-up blood culture be justified in Klebsiella pneumoniae bacteremia? a retrospective case-control study.","volume":"13","author":"Kang","year":"2013","journal-title":"BMC Infect Dis"},{"key":"zoi220927r32","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1093\/ofid\/ofab466.062","article-title":"Follow-up blood culture practices for gram-negative bloodstream infections in immunocompromised hosts at a large academic medical center.","volume":"8","author":"Groft","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"zoi220927r13","unstructured":"IDWeek. Virtual Event Conference. Accessed August 18, 2021. https:\/\/idweek.org\/events\/idweek2021"},{"key":"zoi220927r19","unstructured":"Covidence systematic review software, Veritas Health Innovation. Accessed March 22, 2022. http:\/\/www.covidence.org"},{"key":"zoi220927r20","unstructured":"Wells? GA, Shea? B, O\u2019Connell? D, . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed March 22, 2022. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2796617\/thaden_2022_oi_220927_1663261396.10241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T12:24:52Z","timestamp":1663849492000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2796617"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.32576","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]}}}